![]() |
인쇄하기
취소
|
As assessment that new drugs do not received proper price in domestic expands, some are voicing an opinion which points out that so called 'Access to Medicine' is getting weakened. In particular, they concern that it is possible for multinational pharmaceutical companies with a number of new drugs to give up Korea market.
Then, do multinational pharmaceutical companies really try to give up Ko...